Your browser doesn't support javascript.
loading
Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk.
Allende, Mikel; Molina, Eva; Guruceaga, Elisabet; Tamayo, Ibai; González-Porras, José Ramón; Gonzalez-López, Tomás José; Toledo, Estefanía; Rabal, Obdulia; Ugarte, Ana; Roldán, Vanesa; Rivera, José; Oyarzabal, Julen; Montes, Ramón; Hermida, José.
Afiliação
  • Allende M; Division of Cardiovascular Sciences, Laboratory of Thrombosis and Haemostasis, Center for Applied Medical Research (CIMA), IdiSNA, Navarra's Health Research Institute, University of Navarra, Pío XII, 55, Pamplona, Spain.
  • Molina E; Division of Cardiovascular Sciences, Laboratory of Thrombosis and Haemostasis, Center for Applied Medical Research (CIMA), IdiSNA, Navarra's Health Research Institute, University of Navarra, Pío XII, 55, Pamplona, Spain.
  • Guruceaga E; Proteomics, Genomics & Bioinformatics Unit, Center for Applied Medical Research (CIMA), IdiSNA, Navarra's Health Research Institute, University of Navarra, Pamplona, Spain.
  • Tamayo I; Division of Cardiovascular Sciences, Laboratory of Thrombosis and Haemostasis, Center for Applied Medical Research (CIMA), IdiSNA, Navarra's Health Research Institute, University of Navarra, Pío XII, 55, Pamplona, Spain.
  • González-Porras JR; Department of Haematology, IBSAL-Hospital Universitario de Salamanca, Salamanca, Spain.
  • Gonzalez-López TJ; Servicio de Hematología, Hospital Universitario de Burgos, Burgos, Spain.
  • Toledo E; Department of Preventive Medicine and Public Health, School of Medicine, IdiSNA, Navarra's Health Research Institute, University of Navarra, Pamplona, Spain.
  • Rabal O; Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), IdiSNA, Navarra's Health Research Institute, University of Navarra, Pamplona, Spain.
  • Ugarte A; Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), IdiSNA, Navarra's Health Research Institute, University of Navarra, Pamplona, Spain.
  • Roldán V; Centro Regional de Hemodonación, Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain.
  • Rivera J; Centro Regional de Hemodonación, Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain.
  • Oyarzabal J; Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), IdiSNA, Navarra's Health Research Institute, University of Navarra, Pamplona, Spain.
  • Montes R; Division of Cardiovascular Sciences, Laboratory of Thrombosis and Haemostasis, Center for Applied Medical Research (CIMA), IdiSNA, Navarra's Health Research Institute, University of Navarra, Pío XII, 55, Pamplona, Spain.
  • Hermida J; Division of Cardiovascular Sciences, Laboratory of Thrombosis and Haemostasis, Center for Applied Medical Research (CIMA), IdiSNA, Navarra's Health Research Institute, University of Navarra, Pío XII, 55, Pamplona, Spain jhermida@unav.es.
Cardiovasc Res ; 110(3): 309-18, 2016 06 01.
Article em En | MEDLINE | ID: mdl-26976620

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Trombose / Doenças das Artérias Carótidas / Proteínas de Choque Térmico HSP70 / Acidente Vascular Cerebral Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Trombose / Doenças das Artérias Carótidas / Proteínas de Choque Térmico HSP70 / Acidente Vascular Cerebral Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article